B. Pascual

A novel CXCR4 antagonist IgG1 antibody (PF-06747143) for the treatment of hematologic malignancies.

E. Blasi, T. Smeal, M. Spilker, 2014, Blood advances.

Antisense inhibition of 11betahydroxysteroid dehydrogenase type 1 improves diabetes in a novel cortisone-induced diabetic KK mouse model.

P. Rejto, K. Ogilvie, B. Jessen, 2008, Biochemical and biophysical research communications.

Effective Targeting of Hedgehog Signaling in a Medulloblastoma Model with PF-5274857, a Potent and Selective Smoothened Antagonist That Penetrates the Blood–Brain Barrier

M. Spilker, Meirong Xu, A. Yang, 2011, Molecular Cancer Therapeutics.

Preclinical PK/PD modeling and human efficacious dose projection for a glucokinase activator in the treatment of diabetes

K. Ogilvie, K. Kozminski, Shaoxian Sun, 2014, Journal of Pharmacokinetics and Pharmacodynamics.

4-methylpteridinones as orally active and selective PI3K/mTOR dual inhibitors.

D. Knighton, M. Nambu, K. Liu, 2010, Bioorganic & medicinal chemistry letters.